SuperworthSensus Healthcare profit margin SRTS
Gross, operating and net profit as a share of revenue over the last twelve months, from 2015.
- Net margin, 12 months
- −88.5%
- Operating margin, 12 months
- −75.7%
- Net margin on a year earlier
- −86.2 pts
- Peer median
- 8.4%
Over the twelve months to Jun 30, 2026, Sensus Healthcare kept −88.5% of its revenue as net profit, with an operating margin of −75.7% and a gross margin of 36.4%.
Five years earlier its net margin was −13.6%.
The median for 7 medical instruments and supplies stocks of a similar size is 8.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −28.1% | −37.5% | 43.2% |
| FY2024 | 15.9% | 19.4% | 58.4% |
| FY2023 | 2.0% | −1.6% | 57.6% |
| FY2022 | 54.4% | 33.3% | 66.5% |
| FY2021 | 15.2% | 15.2% | 62.8% |
| FY2020 | −71.4% | −86.0% | 54.8% |
| FY2019 | −6.2% | −7.2% | 64.4% |
| FY2018 | −7.7% | −7.6% | 64.0% |
| FY2017 | −18.0% | −18.1% | 67.0% |
| FY2016 | −2.3% | −2.5% | 66.5% |
| FY2015 | −2.3% | −2.2% | 64.1% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −88.5% | −86.2 pts | −75.7% | |
| Q1 FY26 | −34.5% | −39.1 pts | −53.3% | |
| Q4 FY25 | −28.1% | −44.0 pts | −37.5% | |
| Q3 FY25 | −8.4% | −31.0 pts | −15.3% | |
| Q2 FY25 | −2.3% | −20.5 pts | −3.6% | |
| Q1 FY25 | 4.6% | −10.1 pts | 6.5% | |
| Q4 FY24 | 15.9% | +13.9 pts | 19.4% | |
| Q3 FY24 | 22.5% | +26.1 pts | 28.9% | |
| Q2 FY24 | 18.3% | +10.3 pts | 23.5% | |
| Q1 FY24 | 14.7% | −2.0 pts | 17.2% | |
| Q4 FY23 | 2.0% | −52.5 pts | −1.6% | |
| Q3 FY23 | −3.6% | −63.7 pts | −7.2% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Sensus Healthcare's size, closest first, today.
| Company | Profit margin |
|---|---|
| SRTSSensus Healthcare | −88.5% |
| APTAlpha Pro Tech | 6.8% |
| NEPHNephros | 8.4% |
| KEQUKewaunee Scientific | 3.0% |
| PDEXPro DEX | 17.6% |
| UTMDUtah Medical Products | 29.0% |
| INFUInfuSystem | 6.0% |
| EMBCEmbecta | 8.6% |
| Peer median | 8.4% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Sensus Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.